Key Takeaways

• Healthcare practice valuation in California uses three standard approaches — income (DCF and capitalization of earnings), market (comparable transactions), and asset (adjusted book value). Most healthcare valuations rely primarily on the income approach because the practice’s value derives from its ability to generate future cash flow, with the other approaches as confirmation.
• Fair market value (FMV) is a defined concept: the price at which a practice would change hands between a willing buyer and willing seller, neither under compulsion, both with reasonable knowledge of relevant facts. FMV is essential for B&P § 650(b) MSO fees, Stark Law isolated-transaction exceptions, AKS compliance, and practice acquisitions where federal payor revenue is involved.
• Goodwill is typically the largest component of a healthcare practice’s value, and the hardest to value. California practices have seen goodwill multiples compress over the past 15 years as managed care and consolidation reduced the patient-portability assumptions that goodwill historically reflected.
• Documentation matters as much as methodology. A valuation prepared without FMV documentation, with stale comparables, or without adjustment for practice-specific risk factors won’t survive Stark Law, AKS, or Medical Board scrutiny in a buy/sell or MSO compensation context.
• When third-party appraisals are requiredwhen in-house analysis suffices turns on the use case: any compensation arrangement involving Medicare/Medicaid referrals generally needs third-party FMV; smaller MSA fee structures, partnership buyouts, and routine succession may be done with in-house analysis prepared by counsel and the practice’s financial team.

Why FMV Matters in California Healthcare

Fair market value is not just an academic question for California healthcare practices. It’s a legal requirement under multiple regulatory frameworks that touch most practice operations:

B&P § 650(b) — MSO management fees

For California physician practices operating under an MSO arrangement, B&P § 650(b) permits percentage-of-revenue, flat-fee, or cost-plus management fees — but only if the consideration is commensurate with the fair market value of the services furnished. Epic Medical Management, LLC v. Paquette, 244 Cal. App. 4th 504 (2015), confirmed this is the controlling rule. Without documented FMV support, an MSO fee structure looks like a payment for referrals — unlawful fee-splitting under § 650(a).

The FMV documentation has to refresh as the MSO’s services scope changes and as the practice’s volume changes. A fee structure that was FMV-supported in year one can drift to non-FMV in year five if the MSO’s actual services haven’t kept pace with practice growth.

Stark Law — Isolated Transaction Exception

The federal Stark Law’s isolated transaction exception (42 CFR § 411.357(h)) requires that the consideration in a practice acquisition or other isolated transaction be:

• Consistent with FMV of the assets or services being acquired
• Not determined in any manner that takes into account the volume or value of referrals or other business generated between the parties
• Provided under an arrangement that would be commercially reasonable even if the physician made no referrals
• With no additional transactions between the parties for 6 months after the isolated transaction (with limited exceptions)

The FMV component is essential — an acquisition price that exceeds FMV can void the Stark Law exception, exposing the buyer to Stark Law claims for any DHS referrals from the seller-physician.

Anti-Kickback Statute

The federal AKS prohibits offering or paying remuneration to induce referrals of items or services covered by federal healthcare programs. AKS is intent-based, and FMV documentation is one of the primary defenses to an AKS allegation — payment at FMV is not an inducement for referrals; payment above FMV may be.

Practice Acquisitions (Buy/Sell)

In buy-sell transactions, FMV matters from both sides. The buyer needs to confirm the practice is worth what the buyer is paying. The seller needs to validate the price. Disputes over valuation are common in partnership buy-sells, divorce-related practice valuations, and estate-tax valuations.

Partner Buyouts and Successor Buy-Sells

Buy-sell agreements typically specify a valuation method that’s triggered on a partner’s death, disqualification, retirement, or withdrawal. FMV documentation at the time of the triggering event protects against subsequent disputes by the departing partner or their estate.

Annual MSO Reviews

For California MSO arrangements, annual FMV refresh is a compliance best practice — and one of the seven red flags we cover in our MSO compliance diagnostic.

If you operate an MSO that bills a California professional corporation, you’re contemplating buying or selling a practice, or you’re triggering a buy-sell event, the FMV documentation behind the transaction is part of the deal — not an afterthought. Bay Legal, PC coordinates with healthcare-credentialed valuation firms to structure California practice transactions that survive Stark Law, AKS, and § 650(b) scrutiny. Call (650) 668-8000 or schedule a consultation at baylegal.com/contact.

The Three Standard Valuation Approaches

Healthcare practice valuations use three standard methodologies. A defensible valuation typically considers all three and reconciles them; the relative weight given to each depends on the practice type, the use case, and the available data.

Income Approach

The income approach values the practice based on its ability to generate future cash flow. This is the most commonly applied approach for healthcare practices because the practice’s value derives from its ability to generate income for the owner.

Discounted Cash Flow (DCF) method:

• Project future cash flows (typically 5 years) based on the practice’s historical performance, adjusted for known changes.
• Apply a discount rate that reflects the risk of the cash flows and the cost of capital.
• Calculate the present value of the projected cash flows.
• Add a terminal value capturing cash flows beyond the projection period.

DCF is the most rigorous of the income-approach methods. It requires defensible assumptions about future revenue, expense growth, payor reimbursement trends, and discount rates.

Capitalization of Earnings method:

• Calculate the practice’s normalized earnings (with add-backs for owner-related items, one-time expenses, and other adjustments).
• Apply a capitalization rate that reflects risk and expected growth.
• The result is the practice’s value.

Simpler than DCF but less precise. Often used for smaller practices or as a check on DCF results.

Common DCF / cap-of-earnings issues:

• Overoptimistic revenue projections — a practice’s revenue growth can’t outpace what its market and patient base support.
• Discount rate too low — California physician practices have meaningful risk (payor concentration, single-physician dependence, regulatory exposure) that the discount rate needs to capture.
• Add-back fairness — sellers like add-backs that overstate “normalized” earnings; buyers and appraisers haircut aggressively.

Market Approach

The market approach values the practice based on the prices paid in comparable transactions.

• Guideline transactions method: Identify recent acquisitions of comparable practices (specialty, geographic market, payor mix, size). Apply the implied multiples (price/revenue, price/EBITDA, price/discretionary earnings) to the subject practice.
• Guideline public company method: Compare the practice to publicly traded healthcare companies. Apply size and risk adjustments. Less useful for small physician practices.

The market approach’s main challenge in healthcare is data availability. Most physician practice transactions are private and not publicly disclosed. The Goodwill Registry (Health Care Group) and PracticeLink databases compile transaction data; specialty-specific surveys (MGMA, AMGA, SullivanCotter) provide compensation and benchmark data. None is comprehensive.

For California specifically, regional data is sparse for some specialties. The market approach typically functions as a sanity check on the income approach rather than the primary methodology.

Asset Approach

The asset approach values the practice based on the value of its assets, net of liabilities.

• Adjusted book value method: Start with the balance sheet; adjust each asset to its current market value. Subtract liabilities. The result is the equity value.
• Liquidation value method: Estimate the value if the practice were liquidated (assets sold off, business shut down). Almost always lower than going-concern value.

The asset approach is most useful for practices that aren’t generating positive cash flow (where income approach produces low or negative values). For most operating physician practices, asset approach significantly understates value because it doesn’t capture goodwill.

Goodwill: The Hard Part

In healthcare practice valuations, goodwill is typically the largest single component of value and the hardest to value defensibly.

What goodwill represents

Goodwill in a physician practice typically captures:

• Patient relationships and retention — the probability that existing patients will continue seeing the practice after a change in ownership.
• Provider productivity and reputation — the value of the existing clinical team and their referral relationships.
• Operational maturity — established workflows, systems, staffing, vendor relationships.
• Payor contracts and network participation — established payor agreements that provide revenue stability.
• Location and market positioning — the value of the practice’s physical location, brand, and visibility.

Why goodwill has compressed

Healthcare practice goodwill values have compressed substantially over the past 15-20 years. The historical “1.5-2x revenue” goodwill rule of thumb no longer holds for most specialties.

Drivers of compression:

• Managed care patient assignment: Patients in HMO and managed care plans don’t follow their physicians as easily as patients in fee-for-service did. The patient-portability assumption that supported high goodwill multiples is weaker.
• Physician employment trends: As more physicians work as employees of hospital systems or large groups, the “purchase a practice to enter a market” model has been replaced by “hire physicians directly.”
• Reimbursement declines: Reimbursement-rate declines reduce the cash flow that supports goodwill.
• Hospital and PE roll-up dynamics: Buyers in roll-up transactions often discount goodwill more aggressively than independent buyers.
• Specialty-specific variation: Cosmetic dermatology, dentistry, orthopedics, and certain other specialties have held goodwill multiples better than primary care, gynecology, and some specialty fields.

How to value goodwill

The valuation typically separates personal goodwill (attached to the seller-physician personally — their reputation, skill, patient relationships) from enterprise goodwill (attached to the practice as a business — location, brand, systems, team).

In an acquisition where the seller will continue working at the practice for some period, personal goodwill is partially transferred (because the seller stays). In an acquisition where the seller exits at closing, personal goodwill may not transfer at all, leaving only enterprise goodwill for the buyer.

The tax allocation in an asset-purchase transaction matters here: enterprise goodwill is amortizable over 15 years for the buyer (Section 197); personal goodwill associated with the seller’s covenant not to compete is amortizable separately.

Specialty and Practice-Type Variations

Different healthcare practice types have meaningfully different valuation profiles.

Primary care

• Lower revenue per physician but typically higher patient volume.
• Heavy dependence on payor contracts and managed care arrangements.
• Goodwill multiples typically modest.
• Hospital-system and PE platform interest variable by market.

Specialty practices

• Cosmetic dermatology, plastic surgery, ophthalmology, orthopedics, dental, GI, anesthesia, women’s health: Higher EBITDA margins, stronger PE interest, higher multiples.
• Cardiology, oncology, neurology: Variable; depends on procedural mix and payor relationships.
• Behavioral health, addiction medicine: PE interest has grown substantially since 2020.

Surgical practices

• Higher revenue per physician, often with significant ancillary revenue (ASCs, imaging).
• Valuation has to separate the physician practice from the ancillary services (which often have their own Stark Law and AKS issues).
• ASC participation interest is often valued separately under a separate methodology.

Med spa

• Cash-pay primary; minimal payor concentration risk.
• Treatment-volume scaling potential.
• Compliance overlay (CPOM, good faith exam requirements) affects buyer interest.

IV hydration

• Newer category with limited transaction history.
• CPOM compliance issues significant — non-compliant practices have limited buyer interest.
• Mobile vs. fixed-site distinctions affect valuation.

Telehealth

• Multi-state operations complicate valuation (separate PCs in each state).
• Technology stack and digital infrastructure adds value.
• Patient acquisition costs and retention are central.

Dental practices

• Different goodwill dynamics than physician practices (patient relationships often less portable; insurance dynamics different).
• DSO consolidation activity drives multiples in many markets.
• DCF and capitalization of earnings methods both commonly applied.

When to Use a Third-Party Appraiser

The general rule: any compensation arrangement or transaction that touches the federal fraud and abuse laws should have third-party FMV support.

Third-party appraisal is typically required for:

• MSO management fees in PE-backed or hospital-affiliated arrangements with Medicare/Medicaid revenue
• Physician compensation arrangements with hospitals or health systems
• Practice acquisitions involving federal payor revenue
• Stark Law isolated-transaction exception documentation
• Tax-related valuations (estate tax, gift tax, divorce)
• Buy-sell trigger events where independent valuation is required by the agreement
• Practice acquisitions in PE roll-up transactions

In-house analysis (prepared by counsel and the practice’s financial team) typically suffices for:

• Smaller MSA fee structures with limited federal payor exposure
• Annual MSA FMV refresh (where prior third-party valuation provides the baseline)
• Routine succession planning and partnership buyouts among physician partners
• Internal share valuations for tax reporting where no transaction is occurring

The reasonable middle ground: third-party appraisal at the major event (initial MSA, acquisition, buy-sell trigger), with in-house FMV refresh updates between events.

Mid-content CTA: Selecting and instructing a healthcare-credentialed valuation firm is part of the deal architecture. Bay Legal, PC coordinates with established California healthcare valuation firms for MSO FMV documentation, Stark Law isolated-transaction exception support, buy-sell trigger valuations, and acquisition support — and helps clients understand when third-party appraisal is necessary versus when in-house analysis suffices. Call (650) 668-8000 or schedule a consultation at baylegal.com/contact.

What a Defensible FMV Documentation File Looks Like

For a California healthcare arrangement requiring FMV documentation, the file should typically include:

1. Valuation date and use case. The valuation is point-in-time and use-specific. An FMV for an MSO management fee is different from an FMV for a practice acquisition is different from an FMV for an estate tax filing.
2. Description of the practice or services being valued. Specific scope; not catch-all language.
3. Financial data inputs. Historical financials, normalization adjustments, projection assumptions.
4. Methodology applied. Income approach, market approach, asset approach. Why each was or wasn’t used and how each was weighted.
5. Discount rate or capitalization rate analysis. With supporting evidence (build-up method, comparable companies, market data).
6. Comparable transactions analysis (where applicable).
7. Conclusion of value with the rationale.
8. Limitations and assumptions — what the valuation doesn’t reach, what assumptions could change the conclusion.
9. Credentials of the valuator. Healthcare-credentialed appraisers (AVA, ASA, CVA, with healthcare specialty) carry more weight than generalist appraisers.

The documentation is the work product that defends the arrangement. A valuation conclusion without supporting documentation is essentially indefensible if challenged.

Common Pitfalls in Healthcare Practice Valuation

1. Income projections too aggressive — revenue growth that the market won’t support, expense growth that doesn’t keep pace with revenue.
2. Discount rate too low — physician practices have real risk that the discount rate has to capture.
3. Add-back overstatement — sellers like generous add-backs; buyers and appraisers haircut.
4. Goodwill values out of step with current market — applying 1990s-era goodwill multiples to 2026 practice cash flows.
5. Asset approach used for going-concern practices — typically understates value substantially.
6. Comparable transactions that don’t actually compare (different specialty, different geography, different size, different payor mix).
7. No payor concentration analysis — heavy reliance on one payor adds risk that the discount rate has to reflect.
8. No physician concentration analysis — heavy reliance on one productive physician creates key-person risk.
9. No compliance risk discount — practices with CPOM, fee-splitting, IC misclassification, or Stark/AKS exposure should be discounted accordingly.
10. Stale valuations carried forward — an FMV from 2020 isn’t FMV for a 2026 transaction or compensation arrangement.

Talk to a California Healthcare Practice Valuation Attorney

Practice valuation isn’t a stand-alone exercise — it sits inside transactions, compensation arrangements, and compliance frameworks where the FMV conclusion is part of the legal documentation. Getting the valuation right is part of getting the transaction right.

If you’re operating an MSO, contemplating a practice acquisition, planning a sale, structuring a partnership buy-sell, or building a succession plan, attorneys at Bay Legal, PC coordinate with healthcare-credentialed valuation firms, draft the legal documentation that incorporates the valuation, and structure California healthcare transactions and compensation arrangements that survive Stark Law, AKS, B&P § 650(b), and Medical Board scrutiny. Call (650) 668-8000 or schedule a consultation at baylegal.com/contact.

Frequently Asked Questions

What is fair market value (FMV) in California healthcare?

FMV is the price at which a practice (or services) would change hands between a willing buyer and willing seller, neither under compulsion to act, both with reasonable knowledge of relevant facts. FMV is the controlling concept under B&P § 650(b) (MSO management fees must be commensurate with FMV), the federal Stark Law isolated-transaction exception, the Anti-Kickback Statute, and most California healthcare regulatory frameworks involving compensation arrangements or asset transfers.

Which valuation approach is most commonly used for California medical practices?

The income approach — specifically, DCF or capitalization of earnings — is most commonly applied for operating physician practices because the practice’s value derives from its ability to generate future cash flow. The market approach (comparable transactions) provides a sanity check; the asset approach typically applies only to practices that aren’t generating positive cash flow. A defensible valuation considers all three approaches and reconciles them, with the income approach usually carrying the most weight.

How is goodwill valued in a California medical practice?

Goodwill is typically the largest component of a healthcare practice’s value but the hardest to value defensibly. It captures patient relationships, provider reputation, operational maturity, payor relationships, and market position. Valuation typically separates personal goodwill (attached to the seller-physician) from enterprise goodwill (attached to the practice as a business). Goodwill multiples have compressed substantially over the past 15-20 years due to managed care dynamics, reimbursement pressures, and the shift toward physician employment models. Specialty variation is significant — cosmetic dermatology, orthopedics, and certain other specialties have held goodwill multiples better than primary care.

When do I need a third-party appraisal vs. in-house FMV analysis?

Third-party appraisal is typically required for any compensation arrangement or transaction touching the federal fraud and abuse laws — MSO fees with federal payor revenue, hospital-physician compensation arrangements, practice acquisitions with Medicare/Medicaid revenue, Stark Law isolated-transaction exception documentation. In-house analysis (prepared by counsel and the practice’s financial team) typically suffices for smaller MSA fees with limited federal payor exposure, annual FMV refresh updates, and routine succession planning. The reasonable middle ground is third-party appraisal at major events with in-house FMV refresh between events.

How often should I refresh the valuation of my California medical practice?

For MSO fee structures: annually, or whenever scope or volume materially changes. For partnership buy-sell formulas: annually if formula-based; on the triggering event if appraisal-based. For estate planning: whenever circumstances change materially or every 3-5 years for stable practices. For active transaction work: at the LOI stage and again at the definitive document stage if material time passes. Stale valuations are a recurring problem in California healthcare compliance — an FMV from 2020 isn’t FMV for a 2026 transaction or compensation arrangement.

This article provides general information about California law and is not legal, tax, or financial advice. Reading this article, contacting Bay Legal, PC, or sending information through baylegal.com does not create an attorney-client relationship. The information here focuses on California law and may not reflect the law of other jurisdictions. Statutes, regulations, agency guidance, and case law change; this article reflects the authors’ understanding as of the date of publication and may not reflect later developments. For advice about your specific situation, consult a licensed California attorney and a healthcare-credentialed valuation firm.